nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—Injection site burning—Carmustine—malignant glioma	0.0957	0.0957	CcSEcCtD
Gadobenate Dimeglumine—Sensory disturbance—Temozolomide—malignant glioma	0.0281	0.0281	CcSEcCtD
Gadobenate Dimeglumine—Hemiplegia—Carmustine—malignant glioma	0.0253	0.0253	CcSEcCtD
Gadobenate Dimeglumine—Hemiplegia—Temozolomide—malignant glioma	0.0244	0.0244	CcSEcCtD
Gadobenate Dimeglumine—Intracranial pressure increased—Carmustine—malignant glioma	0.0216	0.0216	CcSEcCtD
Gadobenate Dimeglumine—Faecal incontinence—Carmustine—malignant glioma	0.0179	0.0179	CcSEcCtD
Gadobenate Dimeglumine—Faecal incontinence—Temozolomide—malignant glioma	0.0173	0.0173	CcSEcCtD
Gadobenate Dimeglumine—Visual acuity reduced—Temozolomide—malignant glioma	0.0147	0.0147	CcSEcCtD
Gadobenate Dimeglumine—Deep vein thrombosis—Temozolomide—malignant glioma	0.0143	0.0143	CcSEcCtD
Gadobenate Dimeglumine—Aphasia—Carmustine—malignant glioma	0.0139	0.0139	CcSEcCtD
Gadobenate Dimeglumine—Embolism—Temozolomide—malignant glioma	0.0136	0.0136	CcSEcCtD
Gadobenate Dimeglumine—Aphasia—Temozolomide—malignant glioma	0.0134	0.0134	CcSEcCtD
Gadobenate Dimeglumine—Parosmia—Temozolomide—malignant glioma	0.0134	0.0134	CcSEcCtD
Gadobenate Dimeglumine—Burning sensation—Carmustine—malignant glioma	0.013	0.013	CcSEcCtD
Gadobenate Dimeglumine—Lung disorder—Temozolomide—malignant glioma	0.0123	0.0123	CcSEcCtD
Gadobenate Dimeglumine—Stupor—Carmustine—malignant glioma	0.0121	0.0121	CcSEcCtD
Gadobenate Dimeglumine—Hyperaesthesia—Temozolomide—malignant glioma	0.0111	0.0111	CcSEcCtD
Gadobenate Dimeglumine—Injection site pain—Carmustine—malignant glioma	0.0111	0.0111	CcSEcCtD
Gadobenate Dimeglumine—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.0106	0.0106	CcSEcCtD
Gadobenate Dimeglumine—Extravasation—Carmustine—malignant glioma	0.0103	0.0103	CcSEcCtD
Gadobenate Dimeglumine—Leukocytosis—Carmustine—malignant glioma	0.0096	0.0096	CcSEcCtD
Gadobenate Dimeglumine—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00959	0.00959	CcSEcCtD
Gadobenate Dimeglumine—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00922	0.00922	CcSEcCtD
Gadobenate Dimeglumine—Hearing impaired—Temozolomide—malignant glioma	0.00916	0.00916	CcSEcCtD
Gadobenate Dimeglumine—Pulmonary embolism—Carmustine—malignant glioma	0.00903	0.00903	CcSEcCtD
Gadobenate Dimeglumine—Injection site reaction—Carmustine—malignant glioma	0.00897	0.00897	CcSEcCtD
Gadobenate Dimeglumine—Respiratory failure—Temozolomide—malignant glioma	0.00888	0.00888	CcSEcCtD
Gadobenate Dimeglumine—Pulmonary embolism—Temozolomide—malignant glioma	0.00872	0.00872	CcSEcCtD
Gadobenate Dimeglumine—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00872	0.00872	CcSEcCtD
Gadobenate Dimeglumine—Depressed level of consciousness—Carmustine—malignant glioma	0.00872	0.00872	CcSEcCtD
Gadobenate Dimeglumine—Urinary incontinence—Carmustine—malignant glioma	0.00872	0.00872	CcSEcCtD
Gadobenate Dimeglumine—Depressed level of consciousness—Temozolomide—malignant glioma	0.00842	0.00842	CcSEcCtD
Gadobenate Dimeglumine—Urinary incontinence—Temozolomide—malignant glioma	0.00842	0.00842	CcSEcCtD
Gadobenate Dimeglumine—Abnormal vision—Carmustine—malignant glioma	0.00787	0.00787	CcSEcCtD
Gadobenate Dimeglumine—Abnormal vision—Temozolomide—malignant glioma	0.00761	0.00761	CcSEcCtD
Gadobenate Dimeglumine—Phlebitis—Carmustine—malignant glioma	0.00761	0.00761	CcSEcCtD
Gadobenate Dimeglumine—Swelling—Carmustine—malignant glioma	0.00743	0.00743	CcSEcCtD
Gadobenate Dimeglumine—Ear pain—Temozolomide—malignant glioma	0.00742	0.00742	CcSEcCtD
Gadobenate Dimeglumine—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00728	0.00728	CcSEcCtD
Gadobenate Dimeglumine—Eye pain—Carmustine—malignant glioma	0.00726	0.00726	CcSEcCtD
Gadobenate Dimeglumine—Deafness—Temozolomide—malignant glioma	0.00708	0.00708	CcSEcCtD
Gadobenate Dimeglumine—Eye pain—Temozolomide—malignant glioma	0.00701	0.00701	CcSEcCtD
Gadobenate Dimeglumine—Thirst—Temozolomide—malignant glioma	0.00665	0.00665	CcSEcCtD
Gadobenate Dimeglumine—Hyponatraemia—Carmustine—malignant glioma	0.00658	0.00658	CcSEcCtD
Gadobenate Dimeglumine—Face oedema—Carmustine—malignant glioma	0.00633	0.00633	CcSEcCtD
Gadobenate Dimeglumine—Face oedema—Temozolomide—malignant glioma	0.00611	0.00611	CcSEcCtD
Gadobenate Dimeglumine—Liver function test abnormal—Carmustine—malignant glioma	0.00605	0.00605	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.0057	0.0057	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00558	0.00558	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Temozolomide—malignant glioma	0.00526	0.00526	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Carmustine—malignant glioma	0.00511	0.00511	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Temozolomide—malignant glioma	0.00506	0.00506	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Carmustine—malignant glioma	0.00496	0.00496	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Temozolomide—malignant glioma	0.00494	0.00494	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Carmustine—malignant glioma	0.00491	0.00491	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Temozolomide—malignant glioma	0.00488	0.00488	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Temozolomide—malignant glioma	0.00488	0.00488	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Temozolomide—malignant glioma	0.00474	0.00474	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Carmustine—malignant glioma	0.00451	0.00451	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Carmustine—malignant glioma	0.00447	0.00447	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Carmustine—malignant glioma	0.00445	0.00445	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Carmustine—malignant glioma	0.00437	0.00437	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Temozolomide—malignant glioma	0.00436	0.00436	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Temozolomide—malignant glioma	0.00433	0.00433	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Temozolomide—malignant glioma	0.00432	0.00432	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Temozolomide—malignant glioma	0.0043	0.0043	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Temozolomide—malignant glioma	0.00429	0.00429	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Carmustine—malignant glioma	0.00424	0.00424	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Temozolomide—malignant glioma	0.00422	0.00422	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Carmustine—malignant glioma	0.00421	0.00421	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Temozolomide—malignant glioma	0.00409	0.00409	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Temozolomide—malignant glioma	0.00408	0.00408	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Temozolomide—malignant glioma	0.00407	0.00407	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Temozolomide—malignant glioma	0.00407	0.00407	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Carmustine—malignant glioma	0.00405	0.00405	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Temozolomide—malignant glioma	0.00397	0.00397	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Carmustine—malignant glioma	0.00397	0.00397	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Temozolomide—malignant glioma	0.00396	0.00396	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Temozolomide—malignant glioma	0.00395	0.00395	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Carmustine—malignant glioma	0.00395	0.00395	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Carmustine—malignant glioma	0.00395	0.00395	CcSEcCtD
Gadobenate Dimeglumine—Chills—Temozolomide—malignant glioma	0.00393	0.00393	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Temozolomide—malignant glioma	0.00384	0.00384	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Carmustine—malignant glioma	0.00382	0.00382	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Temozolomide—malignant glioma	0.00381	0.00381	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Temozolomide—malignant glioma	0.00381	0.00381	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Temozolomide—malignant glioma	0.00373	0.00373	CcSEcCtD
Gadobenate Dimeglumine—Tremor—Carmustine—malignant glioma	0.0037	0.0037	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Temozolomide—malignant glioma	0.00369	0.00369	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Carmustine—malignant glioma	0.00365	0.00365	CcSEcCtD
Gadobenate Dimeglumine—Tremor—Temozolomide—malignant glioma	0.00357	0.00357	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Temozolomide—malignant glioma	0.00354	0.00354	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Carmustine—malignant glioma	0.00353	0.00353	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Temozolomide—malignant glioma	0.00352	0.00352	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Temozolomide—malignant glioma	0.00348	0.00348	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Temozolomide—malignant glioma	0.00344	0.00344	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Temozolomide—malignant glioma	0.00341	0.00341	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Carmustine—malignant glioma	0.00341	0.00341	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Temozolomide—malignant glioma	0.00337	0.00337	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Carmustine—malignant glioma	0.00336	0.00336	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Carmustine—malignant glioma	0.00336	0.00336	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Carmustine—malignant glioma	0.00335	0.00335	CcSEcCtD
Gadobenate Dimeglumine—Cough—Temozolomide—malignant glioma	0.00333	0.00333	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Temozolomide—malignant glioma	0.00329	0.00329	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Carmustine—malignant glioma	0.00325	0.00325	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Temozolomide—malignant glioma	0.00325	0.00325	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Temozolomide—malignant glioma	0.00325	0.00325	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Temozolomide—malignant glioma	0.00324	0.00324	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00322	0.00322	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Temozolomide—malignant glioma	0.00321	0.00321	CcSEcCtD
Gadobenate Dimeglumine—Infection—Carmustine—malignant glioma	0.0032	0.0032	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Temozolomide—malignant glioma	0.00317	0.00317	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Carmustine—malignant glioma	0.00314	0.00314	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Temozolomide—malignant glioma	0.00314	0.00314	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Temozolomide—malignant glioma	0.00311	0.00311	CcSEcCtD
Gadobenate Dimeglumine—Infection—Temozolomide—malignant glioma	0.00309	0.00309	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Temozolomide—malignant glioma	0.00305	0.00305	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Temozolomide—malignant glioma	0.00302	0.00302	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Carmustine—malignant glioma	0.00301	0.00301	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Temozolomide—malignant glioma	0.00301	0.00301	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00293	0.00293	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Carmustine—malignant glioma	0.00289	0.00289	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Carmustine—malignant glioma	0.00287	0.00287	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Carmustine—malignant glioma	0.00286	0.00286	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00284	0.00284	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Temozolomide—malignant glioma	0.00279	0.00279	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00278	0.00278	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Temozolomide—malignant glioma	0.00277	0.00277	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Temozolomide—malignant glioma	0.00277	0.00277	CcSEcCtD
Gadobenate Dimeglumine—Pain—Carmustine—malignant glioma	0.00275	0.00275	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Carmustine—malignant glioma	0.00275	0.00275	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Temozolomide—malignant glioma	0.00274	0.00274	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00269	0.00269	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Temozolomide—malignant glioma	0.00268	0.00268	CcSEcCtD
Gadobenate Dimeglumine—Pain—Temozolomide—malignant glioma	0.00266	0.00266	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Temozolomide—malignant glioma	0.00266	0.00266	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Carmustine—malignant glioma	0.00265	0.00265	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Carmustine—malignant glioma	0.00263	0.00263	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Temozolomide—malignant glioma	0.00256	0.00256	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Carmustine—malignant glioma	0.00255	0.00255	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Carmustine—malignant glioma	0.00255	0.00255	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00254	0.00254	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Temozolomide—malignant glioma	0.00247	0.00247	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Temozolomide—malignant glioma	0.00246	0.00246	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Temozolomide—malignant glioma	0.00246	0.00246	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Carmustine—malignant glioma	0.00237	0.00237	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Carmustine—malignant glioma	0.00231	0.00231	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Temozolomide—malignant glioma	0.00229	0.00229	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Temozolomide—malignant glioma	0.00223	0.00223	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Carmustine—malignant glioma	0.0022	0.0022	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Temozolomide—malignant glioma	0.0022	0.0022	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Carmustine—malignant glioma	0.00213	0.00213	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Temozolomide—malignant glioma	0.00213	0.00213	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Temozolomide—malignant glioma	0.00206	0.00206	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Carmustine—malignant glioma	0.00205	0.00205	CcSEcCtD
Gadobenate Dimeglumine—Rash—Carmustine—malignant glioma	0.00203	0.00203	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Carmustine—malignant glioma	0.00203	0.00203	CcSEcCtD
Gadobenate Dimeglumine—Headache—Carmustine—malignant glioma	0.00202	0.00202	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Temozolomide—malignant glioma	0.00198	0.00198	CcSEcCtD
Gadobenate Dimeglumine—Rash—Temozolomide—malignant glioma	0.00196	0.00196	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Temozolomide—malignant glioma	0.00196	0.00196	CcSEcCtD
Gadobenate Dimeglumine—Headache—Temozolomide—malignant glioma	0.00195	0.00195	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Carmustine—malignant glioma	0.00191	0.00191	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Temozolomide—malignant glioma	0.00185	0.00185	CcSEcCtD
